Wednesday, December 23, 2009
FDA Says Data Insufficient To Support Approval For Pfizer's Lyrica As ... - RTT News
FDA Says Data Insufficient To Support Approval For Pfizer's Lyrica As ...
RTT News
Pfizer shares closed Wednesday's regular trading session at $18.58, down 3 cents and lost an additional 2 cents in after hours trading. by RTT Staff Writer.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment